Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results
Crossref DOI link: https://doi.org/10.1186/s12886-016-0305-2
Published Online: 2016-07-27
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kokame, Gregg T.
Lai, James C.
Wee, Raymond
Yanagihara, Ryan
Shantha, Jessica G.
Ayabe, Julia
Hirai, Kelsi
Funding for this research was provided by:
Regeneron
License valid from 2016-07-27